Mars Express: 20 Years of Mission, Science Operations and Data Archiving
Cardesin-Moinelo, A., Godfrey, J., Grotheer, E., Blake, R., Damiani, S., Wood, S., Dressler, T., Bruno, M., Johnstone, A., Lucas, L., Marin-Yaseli de la Parra, J., Merritt, D., Sierra, M., Määttänen, A., Antoja-Lleonart, G., Breitfellner, M., Muniz, C., Nespoli, F., Riu, L., Ashman, M., Escalante, A., Geiger, B., Heather, D., Hepburn, A., Pistone, V., Raga, F., Valles, R., Companys, V., Martin, P., Wilson, C.
Published in Space science reviews (01.03.2024)
Published in Space science reviews (01.03.2024)
Get full text
Journal Article
The search campaign to identify and image the Philae Lander on the surface of comet 67P/Churyumov-Gerasimenko
O'Rourke, L., Tubiana, C., Güttler, C., Lodiot, S., Muñoz, P., Herique, A., Rogez, Y., Durand, J., Charpentier, A., Sierks, H., Gutierrez-Marques, P., Deller, J., Grieger, B., Andres, R., Geiger, B., Geurts, K., Ulamec, S., Kömle, N., Lommatsch, V., Maibaum, M., Pellon, J.L., Bielsa, C., Garmier, R., Taylor, M., Martin, P., Küppers, M., Accomazzo, A., Companys, V., Bibring, J.P., Kofman, W., Mckenna Lawlor, S., Salatti, M., Gaudon, P.
Published in Acta astronautica (01.04.2019)
Published in Acta astronautica (01.04.2019)
Get full text
Journal Article
Mars Express investigations of Phobos and Deimos
Witasse, O., Duxbury, T., Chicarro, A., Altobelli, N., Andert, T., Aronica, A., Barabash, S., Bertaux, J.-L., Bibring, J.-P., Cardesin-Moinelo, A., Cichetti, A., Companys, V., Dehant, V., Denis, M., Formisano, V., Futaana, Y., Giuranna, M., Gondet, B., Heather, D., Hoffmann, H., Holmström, M., Manaud, N., Martin, P., Matz, K.-D., Montmessin, F., Morley, T., Mueller, M., Neukum, G., Oberst, J., Orosei, R., Pätzold, M., Picardi, G., Pischel, R., Plaut, J.J., Reberac, A., Pardo Voss, P., Roatsch, T., Rosenblatt, P., Remus, S., Schmedemann, N., Willner, K., Zegers, T.
Published in Planetary and space science (01.11.2014)
Published in Planetary and space science (01.11.2014)
Get full text
Journal Article
Navigating BepiColombo during the weak-stability capture at Mercury
Jehn, R., Companys, V., Corral, C., Garcı´a Yárnoz, D., Sánchez, N.
Published in Advances in space research (15.10.2008)
Published in Advances in space research (15.10.2008)
Get full text
Journal Article
Crystal structure of avian carboxypeptidase D domain II: a prototype for the regulatory metallocarboxypeptidase subfamily
Gomis-Ruth, F.X, Companys, V, Qian, Y, Fricker, L.D, Vendrell, J, Aviles, F.X, Coll, M
Published in The EMBO journal (01.11.1999)
Published in The EMBO journal (01.11.1999)
Get full text
Journal Article
The Crystal Structure of the Inhibitor-complexed Carboxypeptidase D Domain II and the Modeling of Regulatory Carboxypeptidases
Aloy, Patrick, Companys, Verònica, Vendrell, Josep, Aviles, Francesc X., Fricker, Lloyd D., Coll, Miquel, Gomis-Rüth, F. Xavier
Published in The Journal of biological chemistry (11.05.2001)
Published in The Journal of biological chemistry (11.05.2001)
Get full text
Journal Article
Sun Pharma to acquire Taro's 100% stake in all-cash deal [Times Nation]
In the all cash deal Sun Pharma will acquire the shares at a price of US38 per ordinary share which will be payable in full at the close of the proposed transaction the company said in a BSE filing on Saturday At present Sun holds 7848 stake in TaroIn another development Aalok Shanghvi son of the companys promoter, MD Dilip Shanghvi is joining the companys board as director The companys board appointed him as a wholetime director for a term of five years effective from June 1 2023 Aalok is at present the companys executive VP, head of emerging markets global generic RD global generic business development, APIAalok joined the company in 2006, has handled various roles in marketing RD project management purchase, communications He has done his undergraduate majoring in Cellular, University of Michigan Ann ArborFurther the filing said We believe that the proposed transaction provides a compelling liquidity opportunity for the companys shareholders, will benefit the company, its stakeholdersThe proposed price representsapremium of 312 over Taros closing price on May 25 a 415 premium over Taros average closing price in the last 60 days Sun Pharma said in itsfiling to the exchangesAfter the completion of the deal Sun Pharma will hold 100 of the outstanding share capital of Taro on a fully diluted basis It also announced the appointment of Rolf Hoffmann as an independent director for five years Hoffmann is a strategic, executive, resultsorientated
Published in The Times of India (Online) (28.05.2023)
Get full text
Published in The Times of India (Online) (28.05.2023)
Newspaper Article